Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Epidemiology. 2019 Jan;30(1):112–119. doi: 10.1097/EDE.0000000000000927

Table 2.

Comparison of metal levels in toenails measured at baseline versus 4–10 years later; Sister Study (2003–2009). All cases were breast cancer free at baseline.

Metal Overall (n=221)
Controls (n=110)
Cases (n=111)
Mean differencea 95% CI
Spearman R 95% CI Spearman R 95% CI Spearman R 95% CI
Arsenic 0.40 (0.28, 0.50) 0.37 (0.20, 0.52) 0.42 (0.25, 0.56) −0.04 (−0.10, 0.01)
Cadmium 0.38 (0.26, 0.49) 0.36 (0.19, 0.51) 0.40 (0.23, 0.54) −0.19 (−0.24, −0.13)
Cobalt 0.34 (0.22, 0.45) 0.46 (0.30, 0.59) 0.24 (0.05, 0.41) −0.05 (−0.11, 0.01)
Chromium 0.23 (0.10, 0.35) 0.29 (0.11, 0.45) 0.19 (0.01, 0.37) −0.18 (−0.25, −0.10)
Copper 0.54 (0.44, 0.62) 0.59 (0.45, 0.70) 0.49 (0.34, 0.62) −0.003 (−0.02, 0.02)
Iron 0.40 (0.28, 0.51) 0.45 (0.29, 0.59) 0.36 (0.18, 0.51) −0.03 (−0.08, 0.03)
Mercury 0.71 (0.63, 0.77) 0.74 (0.64, 0.82) 0.67 (0.55, 0.76) −0.07 (−0.12, −0.01)
Manganese 0.41 (0.29, 0.51) 0.46 (0.30, 0.60) 0.37 (0.19, 0.52) −0.10 (−0.18, −0.01)
Molybdenum 0.35 (0.23, 0.46) 0.25 (0.06, 0.42) 0.45 (0.29, 0.59) −0.07 (−0.12, −0.01)
Nickel 0.20 (0.07, 0.32) 0.40 (0.23, 0.54) −0.02 (−0.21, 0.16) −0.16 (−0.28, −0.03)
Lead 0.47 (0.36, 0.57) 0.42 (0.25, 0.56) 0.52 (0.37, 0.64) −0.28 (−0.34, −0.22)
Antimony 0.18 (0.05, 0.31) 0.23 (0.04, 0.40) 0.12 (−0.07, 0.30) −0.01 (−0.08, 0.05)
Selenium 0.58 (0.48, 0.66) 0.65 (0.53, 0.75) 0.51 (0.35, 0.63) −0.002 (−0.02, 0.01)
Tin 0.26 (0.14, 0.38) 0.21 (0.02, 0.38) 0.24 (0.06, 0.41) −0.04 (−0.10, 0.02)
Vanadium 0.45 (0.34, 0.55) 0.41 (0.24, 0.56) 0.49 (0.33, 0.62) −0.05 (−0.12, 0.01)
Zinc 0.64 (0.55, 0.71) 0.66 (0.54, 0.76) 0.62 (0.49, 0.72) 0.01 (−0.00, 0.02)

CI: Confidence Interval

a

Comparing log10 metal levels from toenails collected at the first versus second time points

log10 metal level time 2 – log10 metal level time 1